Kirill Osipov comments on regulation of dependent inventions in Russia

Kirill Osipov, the Head of Legal Department of ARS-Patent, commented on regulation of dependent inventions in Russia for the newspaper “Pharmvestnik” in the light of the Moscow Arbitration Court’s Decision of June 1, 2018, according to which, a first compulsory license may be granted in Russia to a medicament comprising INN Lenalidomide.

More details are available at Pharmvestnik’s website.

Pharmvestnik is the leading specialized weekly newspaper covering the Russian pharmaceutical and related industries with a circulation of 16 200 copies. The newspaper has been issued since 1994.

Make an enquiry

Latest News

Ranking IP STARS 2020

2020-06-25

This year ARS-Patent maintained its presence in the exclusive ranking publication IP STARS of the prestigious media Managing IP. The firm has been ...

Read more
ARS-Patent in ranking IAM Patent 1000

2020-06-18

IAM, the world’s leading IP business media platform, has published the results of the IAM Patent 1000 ranking which identifies the top patent practi...

Read more

View all our News

MEET WITH US

Meet with us at 2019 AIPLA Annual Meeting

2019-10-18

Kirill Osipov, the Head of Legal Department at ARS-Patent, will be attending 2019 AIPLA Annual Meeting on October 24-26 in National Harbor, MD, USA. ...

Read more
Meet ARS-Patent at 4th China Pharma Intellectual Property Summit 2019

2019-10-18

Mikhail Khmara, Managing Partner of ARS-Patent and the Head of Patent Department will attend 4th China Pharma IP Summit 2019 (CPIPS 2019) on October 2...

Read more

See all Events

Back top